GSA Capital Partners’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-18,912
| Closed | -$47K | – | 1704 |
|
|
2020
Q3 | $47K | Buy |
+18,912
| New | +$47K | 0.01% | 1188 |
|
|
2017
Q2 | – | Sell |
-23,107
| Closed | -$84K | – | 2022 |
|
|
2017
Q1 | $84K | Sell |
23,107
-11,900
| -34% | -$43.3K | ﹤0.01% | 1673 |
|
|
2016
Q4 | $93K | Buy |
35,007
+4,100
| +13% | +$10.9K | 0.01% | 1680 |
|
|
2016
Q3 | $101K | Buy |
30,907
+4,600
| +17% | +$15K | 0.01% | 1695 |
|
|
2016
Q2 | $88K | Sell |
26,307
-68,587
| -72% | -$229K | ﹤0.01% | 1678 |
|
|
2016
Q1 | $232K | Sell |
94,894
-105,296
| -53% | -$257K | 0.01% | 1430 |
|
|
2015
Q4 | $657K | Buy |
+200,190
| New | +$657K | 0.03% | 982 |
|
|
2014
Q1 | – | Sell |
-15,479
| Closed | -$94K | – | 1854 |
|
|
2013
Q4 | $94K | Buy |
15,479
+3,179
| +26% | +$19.3K | 0.01% | 1568 |
|
|
2013
Q3 | $81K | Buy |
+12,300
| New | +$81K | 0.01% | 1507 |
|